within Pharmacolibrary.Drugs.ATC.V;

model V03AF04
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 1,
    Cl             = 4.166666666666667,
    adminDuration  = 600,
    adminMass      = 0.1,
    adminCount     = 1,
    Vd             = 0.01,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.0,
    Tlag           = 0
  );

  annotation(Documentation(
    info ="<html><body><p>Calcium levofolinate (also known as levoleucovorin) is the active (L) isomer of folinic acid, used as an adjuvant to enhance the efficacy and reduce the toxicity of methotrexate and as a rescue agent in certain chemotherapy regimens. It is also used in combination with 5-fluorouracil for colorectal cancer therapy. It is approved and in clinical use.</p><h4>Pharmacokinetics</h4><p>Estimated pharmacokinetic parameters for a typical healthy adult patient, as no direct published pharmacokinetic study on calcium levofolinate was found. Parameters were inferred from studies of racemic folinic acid/leucovorin.</p><h4>References</h4><ol></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end V03AF04;
